Cell line · CVCL_D627
Panc02
Cancer cell line, Mus musculus. Mouse pancreatic ductal adenocarcinoma. 52 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. Panc02. Cell lines, record CVCL_D627. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_D627
On this page
Cell line
As Cellosaurus gives it.
- Name
- Panc02
- Accession
- CVCL_D627
- RRID
- RRID:CVCL_D627
- Synonyms
- Panc-02, Panc 02, Pan02, Pan-02, PAN 02, Panc02-H0
- Species
- Mus musculus (Mouse)
- Sex
- Male
- Category
- Cancer cell line
- Diseases
- Mouse pancreatic ductal adenocarcinoma (NCIt C34041)
- Derived from
- Pancreas (in situ)
- Entry created
- 2012-10-22
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers52
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment. | J Exp Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Coixenolide Enhances Antitumor Immunity of Cytotoxic CD8+ T Cells by Inhibiting S100A8/A9-CD36 Axis in Obesity-Associated Pancreatic Adenocarcinoma. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cblb Gene Editing in T Cells Sustains Expansion and Immunogenic CAR T Tumor Killing Under Chronic Antigenic Stimulation. | Cells | 2026 | Its Methods give the RRID and name the line | PubMed | |
| WT1-Targeted Oral Bifidobacterium longum Vaccine Enhances Checkpoint Blockade Efficacy in Pancreatic Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The CD49b (ITGA2) collagen receptor excludes CD8+ T cell infiltration in pancreatic ductal adenocarcinoma. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Betrixaban activates cGAS-STING to promote antitumor immunity without pathological inflammation. | EMBO Mol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting HAS2 to enhance anti-tumor immunity in pancreatic cancer via PD-L1 regulation. | Commun Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| NR2F6 deletion revives CAR-T cell function and induces antigen-agnostic immune memory in solid tumors. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancer. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Spatial Multiomics Analyses Reveal That Diabetes Promotes Pancreatic Cancer Progression by Stimulating Cholesterol-Induced Neutrophil Extracellular Trap Formation. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 52
See all 52 papersRelatives14
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE Panc02-CopGFP | CVCL_F6CA | Cell lines | |
| Derived from it | EDITGENE Panc02-FLUC | CVCL_F5UT | Cell lines | |
| Derived from it | HyCyte Panc02 KO-mAnpep | CVCL_F4E1 | Cell lines | |
| Derived from it | HyCyte Panc02 stable cell line for ggaOVAL overexpression | CVCL_F4W4 | Cell lines | |
| Derived from it | HyCyte Panc02 stable cell line for mCxcr2 overexpression | CVCL_F4NI | Cell lines | |
| Derived from it | HyCyte Panc02-Luc | CVCL_E3IB | Cell lines | |
| Derived from it | HyCyte Panc02-Luc-GFP | CVCL_E3IC | Cell lines | |
| Derived from it | Pan-02-Luc | CVCL_D7FV | Cell lines | |
| Derived from it | Panc02-H7 | CVCL_D628 | Cell lines | |
| Derived from it | Panc02-MUC1 | CVCL_E7SN | Cell lines |
1 to 10 of 14
See all 14 relativesCell banks5
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| CLS | 300501 | CLS | |
| EDITGENE | EDC00279 | EDITGENE | |
| Hysigen | TCM-C811 | Hysigen | |
| NCI-DCTD | PAN 02 | Cellosaurus | |
| Ubigene | YC-C067 | Ubigene |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_D627
GET https://conductscience.org/api/cell-lines/v1/CVCL_D627/papers?page=2